Mental Retardation, X-Linked 95

Watchlist

(log in to enable)

Retrieved

2019-09-22

Source

Omim

Trials

—

Genes

IQSEC2, DLG3, GDI1, PAK3, ACSL4, ARX, MECP2, RPS6KA3, HCFC1, IL1RAPL1, TSPAN7, FTSJ1, ZNF41, DMD, CNKSR2, MID2, AGTR2, UPF3B, CXorf56, FRMPD4, ALG13, SLC9A7, RAB39B, PTCHD1, ZNF81, MED12, ZNF711, ARHGEF6, SYP, CLCN4, USP27X, USP9X, ABCG2, FRAXE, AFF2, STS, OPHN1, ALAS2, POU3F4, SERPINA4, RPS6KA6, THOC2, ANOS1, FMR1, ELK1

Drugs

—

Interested in hearing about new therapies?

Clinical Features

Molinari et al. (2008) reported an Australian family with nonsyndromic X-linked mental retardation. Of 5 sibs, there was 1 healthy girl, 2 girls with mild mental retardation, and 2 boys with severe mental retardation. The 2 affected males had a similar phenotype with the same degree of handicap. Both were in educational classes for the moderately handicapped and were able to hold a limited conversation; however, neither learned to read or write. Both were on disability pensions as adults. Their mother was described as slow and was found to carry the mutation. One affected sister was deceased and had been enrolled in a special class for the mildly handicapped at school, but was not as slow as the brothers.

History

Molinari et al. (2008) identified a mutation in the MAGT1 gene (300715.0001) in affected members of a family with MRX95. Piton et al. (2013) detected this mutation in 13 (5 male and 8 female) of 10,557 chromosomes in the NHLBI Exome Variant Server, and considered variation in the MAGT1 gene to be very unlikely to play a role in X-linked mental retardation.